MimiVax Announces Positive Interim Analysis in Ongoing SurVaxM Clinical Trial
Buffalo, NY., February 12, 2025 Highlights: Ongoing clinical trial of SurVaxM in glioblastoma [SURVIVE] has successfully progressed following an interim analysis of trial data The clinical trial is designed to evaluate the safety,…